Boston Scientific doubles its 4th-quarter earnings as profits surge despite flat sales growth that nevertheless bested Wall Street's estimates.
Boston Scientific (NYSE:BSX) doubled its earnings per share during the 4th quarter on an 80% profit surge eked out despite flat sales growth that still topped analysts' expectations.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1kLGVuY
Cap comentari:
Publica un comentari a l'entrada